Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pivmecillinam 3-day vs 5-day regimen for uncomplicated urinary tract infection in women
2014-001321-32Phase 4Completed
- Sponsor
- Department of Clinical Microbiology, Hvidovre Hospital
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of pivmecillinam in urinary tract infection (UTI) (2 arms), sponsored by Department of Clinical Microbiology, Hvidovre Hospital. Primary endpoint: Co-primary endpoints. Started Apr 2015; status: completed.
02
Drugs
pivmecillinam
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on 2014-001321-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001321-32.